Article information
Full text is only aviable in PDF
BIBLIOGRAFIA
[1.]
B. Van Camp. Anemta in cancer. Eritropoietina na anemia do cancro e ou Quimioterapia -107–108.
[2.]
D. Henry. Anemia of cancer and cancer terapy. Eritropoietina na anemia do cancro e ou Quimioterapia -113–114.
[3.]
D.M.A. Francis.
Perioperative blood transfusion and recurrence of cancer: Is there a direct association?.
J. Surg., 60 (1990), pp. 743-745
[4.]
D.M.A. Francis.
Relathionship between blood transfusion and tumor behavior.
Br. J. Surg., 78 (1991), pp. 1420-1428
[5.]
H. Ludwig, L. Even Sunda, Pecherstorfer Martin.
Recombinant human erythropoietin for the correction of cancer associated anemia with and without concomitant cytologic chemotherapy.
Cancer, 76 (1995), pp. 2319-2329
[6.]
H. Ludwjg, G. Kornek, E. Fritz, M. Krainer.
Erythropoietin treatment of chronic anemia of cancer.
Cancer, 74 (1993), pp. 1234-1239
[7.]
H. Okamoto, N. Saijo, T. Shinkai, K. Egualic.
Chemotherapy – induced anemia in patients with primary lung cancer.
Annals of Oncology, 3 (1992), pp. 819-824
[8.]
N.H. Hyman, Fosterrs, J.E. Demenles, et al.
Blood transfusion and survival after lung cancer resection.
Am. J. Surg., 7 (1985), pp. 149-202
[9.]
N. Milman, H. Sengelov, P. Dombernonsky.
Iron status markers m patients with small cell carcinoma of the lung.
Relation to survival. Br. J. Cancer, 64 (1991), pp. 895-898
[10.]
P.I. Tartter MD, L. Burrows.
Perioperative blood transfusion adversely afects prognosis after resection of state 1 (subset No) non oat – celllung cancer.
J. Thorne Cardiavasc. Surg, 88 (1989), pp. 659-662
[11.]
V. Pastorino, M. Valente, I. Cataldo, et al.
Perioperative blood transfusion and prognosis of resected state la lung cancer.
Eur. J. Cancer Clin. Oncolog., 22 (1986), pp. 1375-1378
[12.]
L.C. Platanias, C.B. Miller, R. Mick, et al.
Treatment of chemotherapy –in duced anemia with recombinant human erythropoietin in cancer patients.
J. Clin. Oncol., 9 (1991), pp. 2021-2026
[13.]
A. Robert, G. Johnson, David Roodman.
Hematologic manifestations of malignancy – Disease -a -Mouth 721-768.
(1989),
[14.]
S. Vijayakman MB, BS, DMRT: Effects of subcutaneous recombinant human erythropoietin in cancer patients receiving radiotherapy: preliminary results of a randomised, open -labeled, phase H trial. J. Radiation Oncology 26:721-729.
[15.]
H.S. Wu, A.G. Ittle.
Perioperative blood transfusionand cancer recurrence.
J. Clin. Oncology, 6 (1988), pp. 1348-1354
Open access
This work is licensed under a Creative Commons Attribution 4.0 International License.
Publish in
Pulmonology
Pulmonology
- Home
- All contents
- Publish your article
- About the journal
- Metrics
- Open access
Article options